DIANA REYES: Open Payments
NPI 1992971758 · PFLUGERVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,797 in 99 payments from 21 companies in 2025. Trend: 2023 $3,022 · 2024 $4,559 · 2025 $1,797
Food & beverage: $1,797
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $280 |
| Janssen Biotech, Inc. | 12 | $191 |
| Arcutis Biotherapeutics, Inc. | 10 | $155 |
| UCB, Inc. | 4 | $139 |
| Novartis Pharmaceuticals Corporation | 6 | $132 |
| Amgen Inc. | 6 | $119 |
| LEO Pharma Inc. | 5 | $112 |
| GENZYME CORPORATION | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $81 |
Products named: TREMFYA, SKYRIZI, Zoryve, Bimzelx, OTEZLA, ADBRY, COSENTYX, Sotyktu.
Industry payments across TX — which companies pay providers there.
